Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
122 studies found for:    Open Studies | niaid
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Interferon Responses in Eczema Herpeticum (ADEH)
Conditions: Atopic Dermatitis;   Eczema Herpeticum;   Herpes Simplex Infections;   Eczema Vaccinatum
Intervention:
2 Recruiting The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial
Condition: Rapid HIV Screening
Interventions: Other: A: Nontargeted rapid HIV screening;   Other: B: Enhanced targeted rapid HIV screening;   Other: C: Traditional targeted rapid HIV screening
3 Unknown  Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers
Condition: HIV Infections
Intervention: Biological: SCBaL/M9
4 Recruiting Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants
Condition: HIV Infections
Intervention: Drug: Raltegravir
5 Recruiting ADRN Barrier/Immunoprofiling Exploratory Pilot Study
Conditions: Dermatitis;   Dermatitis, Atopic
Intervention:
6 Recruiting Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age
Condition: West Nile Virus
Interventions: Biological: WN/DEN4Δ30 Vaccine;   Biological: Placebo
7 Recruiting Bone Marrow Transplantation and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance
Condition: Kidney Transplantation
Interventions: Biological: Antithymocyte globulin (ATG);   Drug: Fludarabine;   Drug: Low dose Pre-transplant cyclophosphamide;   Radiation: Total Body Irradiation;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Methylprednisolone;   Biological: Bone Marrow;   Drug: MESNA;   Drug: Mycophenolate mofetil (MMF);   Drug: Prednisone;   Drug: Filgrastim;   Drug: High dose post-transplant cyclophosphamide
8 Recruiting Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Isoniazid (INH);   Drug: Placebo for isoniazid (INH)
9 Recruiting Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Raltegravir
10 Recruiting Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines
Condition: Influenza, Human
Interventions: Biological: A/swine/Missouri/4296424/2006 (H2N3) x A/Ann Arbor/6/60 ca (H2N3 MO 2006/AA ca);   Biological: A/chicken/Hong Kong/G9/97 (H9N2) x A/Ann Arbor/6/60 ca (H9N2 G9/AA ca);   Biological: 2012-2013 trivalent seasonal live attenuated influenza vaccine (FluMist®);   Biological: Vaccine placebo (Leibovitz-15 [L-15]);   Biological: Vaccine placebo (FluMist®)
11 Recruiting Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at High Risk of Acquiring HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir
12 Recruiting Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV LID ΔM2-2 Vaccine;   Biological: Placebo Vaccine
13 Not yet recruiting Evaluating the Safety and Pharmacokinetics of VRC01, a Potent Anti-HIV Neutralizing Monoclonal Antibody, in HIV-1-Exposed Infants
Condition: HIV Infections
Intervention: Biological: VRC01
14 Not yet recruiting Evaluating the Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Healthy, HIV-Uninfected Adolescents
Condition: HIV Infections
Intervention: Drug: Truvada
15 Unknown  SCOT Scleroderma Treatment Alternative Registry (STAR Registry)
Conditions: Scleroderma, Systemic;   Sclerosis
Intervention: Behavioral: Telephone Call
16 Unknown  Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV
Conditions: Neoplasms, Squamous Cell;   Papillomavirus Infections
Intervention:
17 Recruiting High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
Conditions: Cryptococcal Meningitis;   HIV Infections
Interventions: Drug: Fluconazole;   Drug: Amphotericin B
18 Recruiting Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: BMS-936559;   Drug: Placebo for BMS-936559
19 Recruiting Eosinophilic Esophagitis Databank
Conditions: Esophagitis;   Eosinophilic Esophagitis
Intervention:
20 Recruiting Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Condition: Granulomatous Disease, Chronic
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years